Cochlear Limited has announced the commercial launch of its Nucleus® 6 Sound Processor in the United States. The company says recipients of its new implant will benefit from a wide range of new design features that are easy to use and designed to fit each person’s lifestyle.
Cochlear implants are electronic devices which bypass damaged hair cells in the inner ear, or cochlea, and stimulate the hearing nerve directly. They have become a recognised treatment option for infants as young as 12 months old with profound hearing loss in both ears, children aged two and older with severe-to-profound hearing loss, and adults with moderate-to-profound hearing loss in both ears.
Nucleus 6, the next generation cochlear implant sound processor for Cochlear, is built on a completely new microchip platform with five times the processing power of the market-leading Nucleus 5 System. It features synchronized microphones, advanced SmartSound® technology, the industry’s first data logging capability, and with a future software upgrade, it will provide access to wireless technology without the need for wires or additional neck-worn accessories.
“The US launch of the Nucleus 6 Sound Processor underscores our commitment to providing recipients with the opportunity to hear their best throughout their lifetime,” said Chris Smith, President of Cochlear Americas. “With Nucleus 6, recipients will not only have access to the most powerful sound processor available, but the most reliable implant on the market today. Over the last 30 years, we have delivered the best in hearing technology and we will continue to do so as we introduce future upgrades to the system.”
Source: Cochlear Americas, PR Newswire